Influence of isoflurane on the diastolic pressure-flow relationship and critical occlusion pressure during arterial CABG surgery: a randomized controlled trial
- PMID: 26966644
- PMCID: PMC4783760
- DOI: 10.7717/peerj.1619
Influence of isoflurane on the diastolic pressure-flow relationship and critical occlusion pressure during arterial CABG surgery: a randomized controlled trial
Abstract
The effects of isoflurane on the determinants of blood flow during Coronary Artery Bypass Graft (CABG) surgery are not completely understood. This study characterized the influence of isoflurane on the diastolic Pressure-Flow (P-F) relationship and Critical Occlusion Pressure (COP) during CABG surgery. Twenty patients undergoing CABG surgery were studied. Patients were assigned to an isoflurane or control group. Hemodynamic and flow measurements during CABG surgery were performed twice (15 minutes after the discontinuation of extracorporeal circulation (T15) and again 15 minutes later (T30)). The zero flow pressure intercept (a measure of COP) was extrapolated from a linear regression analysis of the instantaneous diastolic P-F relationship. In the isoflurane group, the application of isoflurane significantly increased the slope of the diastolic P-F relationship by 215% indicating a mean reduction of Coronary Vascular Resistance (CVR) by 46%. Simultaneously, the Mean Diastolic Aortic Pressure (MDAP) decreased by 19% mainly due to a decrease in the systemic vascular resistance index by 21%. The COP, cardiac index, heart rate, Left Ventricular End-Diastolic Pressure (LVEDP) and Coronary Sinus Pressure (CSP) did not change significantly. In the control group, the parameters remained unchanged. In both groups, COP significantly exceeded the CSP and LVEDP at both time points. We conclude that short-term application of isoflurane at a sedative concentration markedly increases the slope of the instantaneous diastolic P-F relationship during CABG surgery implying a distinct decrease with CVR in patients undergoing CABG surgery.
Keywords: Cardiac anesthesia; Cardiac surgery; Cardio; Cardioprotective effects; Coronary blood flow; Critical care medicine; Hemodynamic monitoring; Inhalational anesthetic agent.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Bignami E, Greco T, Barile L, Silvetti S, Nicolotti D, Fochi O, Cama E, Costagliola R, Landoni G, Biondi-Zoccai G, Zangrillo A. The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies. Journal of Cardiothoracic Vascular Anesthesia. 2013;27(1):50–58. doi: 10.1053/j.jvca.2012.06.007. - DOI - PubMed
-
- Buffington CW, Romson JL, Levine A, Duttlinger NC, Huang AH. Isoflurane induces coronary steal in a canine model of chronic coronary occlusion. Anesthesiology. 1987;66(3):280–292. - PubMed
-
- Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology. 2005;102(1):102–109. - PubMed
-
- Crystal GJ, Zhou X, Gurevicius J, Czinn EA, Salem MR, Alam S, Piotrowski A, Hu G. Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology. 2000;92(4):1103–1113. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources